FY24 RWHAP Part A Non-Competing Continuation Progress Report
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 11/30/2023
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource from the RWHAP Best Practices Compilation updated on 01/19/2024
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 11/02/2023
Resource from the RWHAP Best Practices Compilation updated on 11/17/2023
Resource updated 04/03/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
A panel of parents who have domestically and internationally adopted youth with HIV discuss the complexities that arise from disclosure, care coordination/engagement, sexuality and dating, and transition to adult care while sharing their individual parenting strategies and struggles.
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 03/18/2024
Resource from the RWHAP Best Practices Compilation updated on 03/18/2024
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024